My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 251

    1.

    Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators.

    Greendale GA, Reboussin BA, Sie A, Singh HR, Olson LK, Gatewood O, Bassett LW, Wasilauskas C, Bush T, Barrett-Connor E.

    Ann Intern Med. 1999 Feb 16;130(4 Pt 1):262-9.PMID: 10068383 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Postmenopausal hormone therapy and change in mammographic density.

    Greendale GA, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Ursin G.

    J Natl Cancer Inst. 2003 Jan 1;95(1):30-7.PMID: 12509398 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.

    Ursin G, Palla SL, Reboussin BA, Slone S, Wasilauskas C, Pike MC, Greendale GA.

    J Clin Oncol. 2004 Jul 15;22(14):2842-8.PMID: 15254051 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

    [No authors listed]

    JAMA. 1995 Jan 18;273(3):199-208. Erratum in: JAMA 1995 Dec 6;274(21):1676. PMID: 7807658 [PubMed - indexed for MEDLINE]Related articles

    5.

    Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.

    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS; Women's Health Initiative Mammogram Density Study Investigators.

    J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76.PMID: 16174858 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

    [No authors listed]

    JAMA. 1996 Feb 7;275(5):370-5.PMID: 8569016 [PubMed - indexed for MEDLINE]Related articles

    7.

    Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH; Women's Health Initiative Memory Study.

    JAMA. 2004 Jun 23;291(24):2947-58.PMID: 15213206 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.

    Barrett-Connor E, Slone S, Greendale G, Kritz-Silverstein D, Espeland M, Johnson SR, Waclawiw M, Fineberg SE.

    Maturitas. 1997 Jul;27(3):261-74.PMID: 9288699 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

    [No authors listed]

    JAMA. 1996 Nov 6;276(17):1389-96.PMID: 8892713 [PubMed - indexed for MEDLINE]Related articles

    10.

    Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

    Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML; WHI Investigators.

    JAMA. 2008 Mar 5;299(9):1036-45.PMID: 18319414 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of estrogen with and without progestin on urinary incontinence.

    Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG.

    JAMA. 2005 Feb 23;293(8):935-48.PMID: 15728164 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

    Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A; WHI Investigators.

    JAMA. 2003 Jun 25;289(24):3243-53.PMID: 12824205 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

    Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett ED, Lane DS, Hubbell FA, Assaf AR, Sarto GE, Schenken RS, Yasmeen S, Lessin L, Chlebowski RT; WHI Investigators.

    JAMA. 2006 Apr 12;295(14):1647-57.PMID: 16609086 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.

    Crandall CJ, Guan M, Laughlin GA, Ursin GA, Stanczyk FZ, Ingles SA, Barrett-Connor E, Greendale GA.

    Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1674-81.PMID: 18628419 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy.

    Crandall CJ, Karlamangla A, Huang MH, Ursin G, Guan M, Greendale GA.

    Arch Intern Med. 2006 Aug 14-28;166(15):1578-84. Erratum in: Arch Intern Med. 2006 Nov 13;166(20):2176. PMID: 16908790 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2663-72.PMID: 12771113 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of estrogen therapy on gallbladder disease.

    Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC.

    JAMA. 2005 Jan 19;293(3):330-9.PMID: 15657326 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

    Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J; WHIMS Investigators.

    JAMA. 2003 May 28;289(20):2651-62.PMID: 12771112 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

    Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators.

    JAMA. 2003 Oct 1;290(13):1729-38.PMID: 14519707 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Estrogen plus progestin and risk of venous thrombosis.

    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

    JAMA. 2004 Oct 6;292(13):1573-80.PMID: 15467059 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity